Stereoselective disposition of flurbiprofen in uraemic patients.
Open Access
- 1 April 1992
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 33 (4), 377-383
- https://doi.org/10.1111/j.1365-2125.1992.tb04055.x
Abstract
1. Both single and multiple oral doses of 50 mg racemic flurbiprofen were given to eight patients with mild to moderate renal impairment. The plasma and urine concentrations of the R- and S-enantiomers of flurbiprofen and its major metabolites were measured by a stereoselective h.p.l.c. assay. 2. For R-flurbiprofen the oral clearance (mean +/- s.d.: 38.3 +/- 12.8 vs 30.8 +/- 11.5 ml min-1) and volume of distribution (Vz; 17.6 +/- 3.9 vs 14.6 +/- 2.5 l) were significantly greater (P less than 0.05) than for the S-enantiomer. A significantly greater (P less than 0.05) percent of the dose was excreted in the urine R-configuration (16.4 +/- 6.0 vs 10.9 +/- 4.2%). 3. Plasma protein binding of the enantiomers of flurbiprofen was determined by ultrafiltration. The unbound clearance and unbound Vz were not different between enantiomers consistent with the (not significantly) greater percent unbound of R-flurbiprofen (0.079 +/- 0.014%) vs S-flurbiprofen (0.064 +/- 0.015%). 4. Relative to normal volunteers, the uraemic subjects exhibited a significantly greater (P less than 0.05) oral clearance, Vz and percent unbound for both enantiomers; unbound clearance and unbound Vz did not differ from healthy controls. 5. The disposition of flurbiprofen enantiomers was not changed upon multiple dosing and no evidence of futile cycling was found. Adjustment of flurbiprofen dosing rate in uraemic subjects is not indicated on the basis of pharmacokinetics.This publication has 25 references indexed in Scilit:
- Stereoselective arylpropionyl‐CoA thioester formation in vitroChirality, 1990
- Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs—1: In vitro studies of ibuprofen and flurbiprofenBiochemical Pharmacology, 1989
- Stereoselective pharmacokinetics of flurbiprofen in humans and ratsJournal of Pharmaceutical Sciences, 1988
- Types of mean residence timesBiopharmaceutics & Drug Disposition, 1988
- Protein Binding as a Primary Determinant of the Clinical Pharmacokinetic Properties of Non-Steroidal Anti-Inflammatory DrugsClinical Pharmacokinetics, 1987
- Pharmacokinetics of flurbiprofen in man. I. Area/dose relationshipsBiopharmaceutics & Drug Disposition, 1987
- The Importance of Stereochemistry in the Clinical Pharmacokinetics of the 2-Arylpropionic Acid Non-Steroidal Anti-Inflammatory DrugsClinical Pharmacokinetics, 1984
- Pharmacokinetics of Ketoprofen in Patients with Chronic Renal FailureScandinavian Journal of Rheumatology, 1981
- The Disposition and Metabolism of Flurbiprofen in Several Species Including ManXenobiotica, 1978
- Renal Failure, Drug Pharmacokinetics and Drug ActionClinical Pharmacokinetics, 1976